BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 21427693)

  • 1. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort.
    Fagherazzi G; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1171-5. PubMed ID: 22623708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women.
    Pinheiro RL; Sarian LO; Pinto-Neto AM; Morais S; Costa-Paiva L
    Breast; 2009 Feb; 18(1):8-12. PubMed ID: 19041243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
    Potter JD; Cerhan JR; Sellers TA; McGovern PG; Drinkard C; Kushi LR; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):319-26. PubMed ID: 7655325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
    Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
    Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and risk of the less commonly diagnosed subtypes of breast cancer.
    Stark A; Schultz D; Kapke A; Nadkarni P; Burke M; Linden M; Raju U
    Eur J Surg Oncol; 2009 Sep; 35(9):928-35. PubMed ID: 19121564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.
    Fagherazzi G; Guillas G; Boutron-Ruault MC; Clavel-Chapelon F; Mesrine S
    Eur J Cancer Prev; 2013 Jan; 22(1):29-37. PubMed ID: 22694827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE
    Breast Cancer Res Treat; 2006 May; 97(1):97-106. PubMed ID: 16319973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmö Diet and Cancer cohort.
    Wirfält E; Li C; Manjer J; Ericson U; Sonestedt E; Borgquist S; Landberg G; Olsson H; Gullberg B
    Nutr Cancer; 2011; 63(5):722-33. PubMed ID: 21767080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen and progesterone receptors in human ductal invasive breast carcinoma not otherwise specified: is there any difference between premenopausal and postmenopausal women?
    Petricević J; Petković M; Jonjić N
    Acta Clin Croat; 2011 Jun; 50(2):169-75. PubMed ID: 22263379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status.
    Shin A; Kim J; Lim SY; Kim G; Sung MK; Lee ES; Ro J
    Nutr Cancer; 2010; 62(4):476-83. PubMed ID: 20432168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.